Dublin-listed Open Orphan to test Covid-19 drug through London subsidiary
As many as 100 potential Covid-19 candidate vaccines are now under development by biotech and research teams around the world
A team at Oxford University in Britain has dosed the first volunteers in a trial of its Covid-19 vaccine “ChAdOx1 nCoV-19” . Photograph: iStock
The testing is being carried out on behalf of Nearmedic International, a specialist pharmaceutical, biotechnological and medical company headquartered in Moscow.